The US FDA has approved Aurobindo Pharma's Lisinopril and Hydrochlorothiazide tablets, 10 / 12.5 mg, 20 / 12.5 mg, and 20 / 25 mg.

The market opportunity for the above product is around USD 100 million. With this approval company's product basket for the USA market has gone upto eleven, said a release.

This combination belongs to the class of medicines called high blood pressure medicines (antihypertensives). It is used to treat high blood pressure (hypertension).

Lisinopril and Hydrochlorothiazide tablets, 10 / 12.5 mg, 20 / 12.5 mg, and 20 / 25 mg is the generic version of Prinzide Tablets, 10 / 12.5 mg, 20 / 12.5 mg, and 20 / 25 mg of Merck research Laboratories.